ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 749292 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 749292; 2) Community: the network communities that were significantly associated with the response to NSC 749292; 3) Molecule: the relationships between components within communities and NSC 749292; 4) MDR: the compounds that were significantly associated with the NSC 749292.

NSC Compound Enrichment Correlation
NSC 637993 6H-Imidazo[4,5,1-de]acridin-6-one, 5-[2-(diethylamino) ethylamino]-8-methoxy-1-methyl-, dihydrochloride 0.0462077035966081 0.41710294
NSC 638748 Tetrakis(8-chinolineolato)titanium(IV)-tetrahydrochloride 0.0462077035966081 0.39182871
NSC 639981 Null 0.0462077035966081 0.51845871
NSC 642276 Null 0.0462077035966081 0.18558501
NSC 645317 Sanguilutine pseudobase 0.0462077035966081 0.36968777
NSC 645727 Carbamothioic acid, 4-chloro-3-[(1-methylethoxy) iminomethyl]-, S-(1-methylethyl) ester 0.0462077035966081 0.47819088
NSC 657561 (Z)-4-bromo-4-iodo-3-phenyl-3-buten-2-one 0.0462077035966081 0.48521067
NSC 672131 Null 0.0462077035966081 0.31884903
NSC 673650 4-Piperidinone, 1-methyl-2,6-bis[(2-nitrophenyl)methylene]- 0.0462077035966081 0.65483075
NSC 679002 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl]-, diethyl ester, cis- 0.0462077035966081 0.65114777
Total:105  Current:100    [First] [Prev] [Next] [Last]